For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $7.50 in the prior trading day, Myriad Genetics, Inc (NASDAQ: MYGN) closed at $7.20, down -4.00%. In other words, the price has decreased by -$4.00 from its previous closing price. On the day, 1.63 million shares were traded.
Ratios:
Our goal is to gain a better understanding of MYGN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.65 and its Current Ratio is at 1.82. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.18.
On March 12, 2025, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $11.50 to $12.50.
On February 12, 2025, Craig Hallum started tracking the stock assigning a Buy rating and target price of $29.Craig Hallum initiated its Buy rating on February 12, 2025, with a $29 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 11 ’24 when DIAZ PAUL J sold 15,000 shares for $22.93 per share. The transaction valued at 343,950 led to the insider holds 962,378 shares of the business.
DIAZ PAUL J bought 15,000 shares of MYGN for $343,950 on Oct 11 ’24. On Aug 21 ’24, another insider, Ancona Margaret, who serves as the Officer of the company, bought 11,538 shares for $27.82 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.79 while its Price-to-Book (P/B) ratio in mrq is 0.94.
Stock Price History:
Over the past 52 weeks, MYGN has reached a high of $29.30, while it has fallen to a 52-week low of $7.16. The 50-Day Moving Average of the stock is -25.43%, while the 200-Day Moving Average is calculated to be -59.91%.
Shares Statistics:
A total of 91.30M shares are outstanding, with a floating share count of 88.14M. Insiders hold about 4.37% of the company’s shares, while institutions hold 100.32% stake in the company.
